A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease
Acta Pharmaceutica Sinica B
; (6): 4032-4044, 2021.
Article
de En
| WPRIM
| ID: wpr-922458
Bibliothèque responsable:
WPRO
ABSTRACT
Insurmountable blood‒brain barrier (BBB) and complex pathological features are the key factors affecting the treatment of Alzheimer's disease (AD). Poor accumulation of drugs in lesion sites and undesired effectiveness of simply reducing A
Texte intégral:
1
Base de données:
WPRIM
Langue:
En
Journal:
Acta Pharmaceutica Sinica B
Année:
2021
Type de document:
Article